BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

BioNTech SE

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 10, 2026

$89.21+1.50 (+1.71%)

Close on Oct 19, 2026

BioNTech SE revenue by segment

BioNTech does not break out revenue by segment, region or product in the tagged data of its filings for this period type.